Nurix Therapeutics (NRIX) Earnings Date, Estimates & Call Transcripts $10.14 +0.49 (+5.08%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$10.12 -0.03 (-0.25%) As of 08/22/2025 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nurix Therapeutics Earnings Summary Nurix Therapeutics released Q2 2025 earnings on July 9, 2025, reporting an EPS of -$0.52, which topped analysts' consensus estimates of -$0.79 by $0.27. Quarterly revenue was reported to be $44,056 billion, above analyst estimates of $16.26 million. With a trailing EPS of -$2.61, Nurix Therapeutics' earnings are expected to decrease next year, from ($2.99) to ($3.01) per share. Upcoming Q3 Earnings DateOct. 10EstimatedConsensus EPS (Jul. 9) -$0.79 Actual EPS (Jul. 9) -$0.52 Beat By $0.27 Actual Revenue (Jul. 9) $44,056.00BQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)NRIX Upcoming EarningsNurix Therapeutics' next earnings date is estimated for Friday, October 10, 2025, based on past reporting schedules. Powered by Get Nurix Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nurix Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNRIX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRIX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Nurix Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.89-$0.60-$0.75Q2 20252-$0.84-$0.62-$0.73Q3 20252-$0.96-$0.68-$0.82Q4 20252-$0.99-$0.89-$0.94 FY 2025 8 -$3.68 -$2.79 -$3.24 Q1 20262-$1.03-$0.91-$0.97Q2 20262-$1.09-$0.94-$1.02Q3 20262-$1.15-$0.97-$1.06Q4 20262-$1.01-$0.91-$0.96 Nurix Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/10/2025(Estimated)--------7/9/2025Q2 2025-$0.79-$0.52+$0.27-$0.52$16.26M$44,056.00B4/8/2025Q1 2025-$0.72-$0.67+$0.05-$0.67$12.78M$18.45M1/28/2025Q4 2024-$0.67-$0.75 -$0.08-$0.75--10/11/2024--$0.67-$0.67--$0.67$13.85M$12.59M7/11/2024Q2 2024-$0.63-$0.71 -$0.08-$0.71$19.35M$12.09M4/10/2024Q1 2024-$0.80-$0.76+$0.04-$0.76$14.58M$16.59M2/15/2024Q4 2023-$0.51-$0.77 -$0.26-$0.77$30.66M$15.16M10/12/2023Q3 2023-$0.84-$0.68+$0.16-$0.68$19.98M$18.47M Nurix Therapeutics Earnings - Frequently Asked Questions When is Nurix Therapeutics' earnings date? Nurix Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 10th, 2025 based off last year's report dates. Learn more on NRIX's earnings history. Did Nurix Therapeutics beat their earnings estimates last quarter? In the previous quarter, Nurix Therapeutics (NASDAQ:NRIX) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.27. Learn more on analysts' earnings estimate vs. NRIX's actual earnings. How much revenue does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded annual revenue of $54.55 million. How much profit does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded net income of -$193.57 million. NRIX has generated -$2.61 earnings per share over the last four quarters. What is Nurix Therapeutics' EPS forecast for next year? Nurix Therapeutics' earnings are expected to decrease from ($2.99) per share to ($3.01) per share in the next year. More Earnings Resources from MarketBeat Related Companies Bausch Health Cos Earnings Date Kymera Therapeutics Earnings Date Scholar Rock Earnings Date AMNEAL PHARMACEUTICALS Earnings Date Xenon Pharmaceuticals Earnings Date Crinetics Pharmaceuticals Earnings Date Ultragenyx Pharmaceutical Earnings Date Arrowhead Pharmaceuticals Earnings Date NewAmsterdam Pharma Earnings Date Immunovant Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:NRIX) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access